Collectively, our results demonstrated that bFGF-RBC/NP could attenuate sepsis-induced cardiac injury by antioxidative and anti-inflammatory effects and showed better therapeutic effects than free bFGF. The gene discussed is FGF2; the disease is Sepsis.